A high-level inter-ministerial group chaired by the prime minister has decided to continue with the 100% foreign direct investment regime i...

Pfizer's $68-billion buyout of Wyeth may help catapult its local subsidiary into the top ten league of Indian drugmakers.

There are hundreds of instances where a company’s plea to register a trademark for its drug is vehemently being opposed by a rival firm.

Alarmed by the government’s move to bring more medicines under cost-based price control.